These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16022180)

  • 1. Recent advances in estrogen receptor modulators.
    Henke BR; Heyer D
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):437-48. PubMed ID: 16022180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor?
    Khosla S
    Trends Pharmacol Sci; 2003 Jun; 24(6):261-3. PubMed ID: 12823947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular determinants of estrogen receptor pharmacology.
    McDonnell DP
    Maturitas; 2004 Aug; 48 Suppl 1():S7-12. PubMed ID: 15337242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and clinical applications of selective estrogen receptor modulators.
    Nath A; Sitruk-Ware R
    Climacteric; 2009 Jun; 12(3):188-205. PubMed ID: 19387883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease.
    Bolego C; Vegeto E; Pinna C; Maggi A; Cignarella A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2192-9. PubMed ID: 16917104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
    J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific modulators of estrogen action].
    Guiochon-Mantel A
    Gynecol Obstet Fertil; 2000 Jun; 28(6):429-34. PubMed ID: 10935307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
    McCafferty MP; McNeill RE; Miller N; Kerin MJ
    Breast Cancer Res Treat; 2009 Aug; 116(3):425-32. PubMed ID: 19507020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer, estrogen receptor and ligands.
    Bai Z; Gust R
    Arch Pharm (Weinheim); 2009 Mar; 342(3):133-49. PubMed ID: 19274700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
    Blizzard TA; Dininno F; Morgan JD; Chen HY; Wu JY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Fitzgerald PM; Sharma N; Li Y; Zhang Z; Hayes EC; Dasilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Jan; 15(1):107-13. PubMed ID: 15582421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based discovery as an approach to identify the next generation of estrogen receptor modulators.
    McDonnell DP
    FASEB J; 2006 Dec; 20(14):2432-4. PubMed ID: 17142791
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 18. New agents in development for breast cancer.
    Gao XP; Liu F
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):68-74. PubMed ID: 17218855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
    Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.